'Aggressive' low grade lymphocytic lymphomas can be identified by flow cytometric S-phase determinations

Area of Science:

• Oncology
• Hematology
• Cell Biology

Background:

• Low-grade non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoid malignancies.
• Accurate prognostic markers are crucial for guiding treatment decisions and predicting patient outcomes.

Purpose of the Study:

• To investigate the prognostic significance of the S-phase cell fraction in patients with low-grade lymphomas.
• To determine if S-phase fraction can predict survival in different subtypes of low-grade NHL.

Main Methods:

• Flow cytometric analysis was used to determine the S-phase fraction in fresh tumor samples from 45 patients with low-grade lymphomas.
• Patients were treated based on stage (radiotherapy for stage I, Prednimustine for stages II-IV) and symptoms.
• Cox multivariate analysis was employed, including age, constitutional symptoms, stage, and morphology as covariates.

Main Results:

• The median S-phase fraction across all samples was 2.0%.
• Patients with lymphocytic lymphomas and S-phase fractions > 2.0% had significantly shorter survival compared to those with lower fractions.
• No significant survival difference was observed in immunocytic or follicular/diffuse centroblastic/centrocytic lymphoma subgroups based on S-phase fraction.

Conclusions:

• The S-phase cell fraction is a statistically significant prognostic parameter for low-grade lymphomas, particularly lymphocytic lymphomas.
• Elevated S-phase fraction identifies a subset of patients with poorer prognosis, aiding in risk stratification and treatment planning.